Found: 2
Select item for more details and to access through your institution.
Concurrent epirubicin and trastuzumab use increases complete pathological response rate without additional cardiotoxicity in patients with human epidermal growth factor receptor 2‐positive early breast cancer: A meta‐regression analysis.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 14, p. 1, doi. 10.1002/cam4.70005
- By:
- Publication type:
- Article
Study on dynamic response of multi-degree-of-freedom explosionvessel system under impact load.
- Published in:
- Defence Technology, 2020, v. 16, n. 4, p. 777, doi. 10.1016/j.dt.2019.08.012
- By:
- Publication type:
- Article